These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 16173841)
1. Tamoxifen and the singing voice. Herxheimer A PLoS Med; 2005 Sep; 2(9):e310. PubMed ID: 16173841 [No Abstract] [Full Text] [Related]
2. Tamoxifen: to use or not to use. Yin CS Taiwan J Obstet Gynecol; 2008 Mar; 47(1):129-30. PubMed ID: 18400603 [No Abstract] [Full Text] [Related]
3. Tamoxifen and growth of an extrauterine leiomyoma. Bayya J; Minkoff H; Khulpateea N Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):90-1. PubMed ID: 18848745 [No Abstract] [Full Text] [Related]
4. Bone builder vs. breast cancer. Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491 [No Abstract] [Full Text] [Related]
5. Follow-up of patients with early breast cancer. Sakemi H N Engl J Med; 2007 Sep; 357(10):1052-3; author reply 1053. PubMed ID: 17804856 [No Abstract] [Full Text] [Related]
6. Some antidepressants interfere with tamoxifen more than others. Harv Womens Health Watch; 2010 Mar; 17(7):6. PubMed ID: 20480970 [No Abstract] [Full Text] [Related]
7. Toremifene: an evaluation of its safety profile. Harvey HA; Kimura M; Hajba A Breast; 2006 Apr; 15(2):142-57. PubMed ID: 16289904 [TBL] [Abstract][Full Text] [Related]
8. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective. Goldhaber SZ Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272 [No Abstract] [Full Text] [Related]
9. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer]. Tuxen MK; Nielsen DL; Lindberg H; Kamby C Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922 [TBL] [Abstract][Full Text] [Related]
11. Raloxifene works as well as tamoxifen in preventing invasive breast cancer. Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270 [No Abstract] [Full Text] [Related]
13. Raloxifene (Evista) for breast cancer prevention in postmenopausal women. Med Lett Drugs Ther; 2006 May; 48(1234):37. PubMed ID: 16685245 [TBL] [Abstract][Full Text] [Related]
14. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen. Booth CM; Pater JL; Goss PE Cancer; 2007 May; 109(9):1927-8; author reply 1928. PubMed ID: 17354227 [No Abstract] [Full Text] [Related]
15. Adjuvant endocrine treatment of early breast cancer. Lønning PE Hematol Oncol Clin North Am; 2007 Apr; 21(2):223-38. PubMed ID: 17512446 [TBL] [Abstract][Full Text] [Related]
16. Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy. Eisner A; O'Malley JP; Incognito LJ; Toomey MD; Samples JR Curr Eye Res; 2006 Apr; 31(4):367-79. PubMed ID: 16603470 [TBL] [Abstract][Full Text] [Related]
17. Understanding the BIG results: Insights from the BIG 1-98 trial analyses. Wardley AM Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768 [TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer. Cohen I Fertil Steril; 2011 Sep; 96(3):e147; author reply e148. PubMed ID: 21762898 [No Abstract] [Full Text] [Related]
19. Relationship between tamoxifen use and high risk endometrial cancer histologic types. Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966 [TBL] [Abstract][Full Text] [Related]
20. Education and imaging: hepatobiliary and pancreatic: focal steatohepatitis mimicking a metastasis. Choi JS; Kim MJ J Gastroenterol Hepatol; 2011 Feb; 26(2):415. PubMed ID: 21261737 [No Abstract] [Full Text] [Related] [Next] [New Search]